FDA Adding More Pediatric Data To Labeling
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA divisions will be more aggressive in requiring pediatric data be included in labeling following recommendation by Office of New Drugs Director Jenkins. However, the added language in labeling will not necessarily clarify whether a drug is safe for use in children, Office of Pediatric Therapeutics Director Murphy notes.